Community Leaders and PIPAR Pharmacies Share Experiences
Requirements for starting and operating a pharmacist-led PrEP…
MWAETC and UW Programs to support pharmacists
Overview of PrEP DAP Program in Washington State
Review of the DAWNING trial and the NADIA trial
Purpose of PrEP Navigators and What Services They Provide
Rationale and results of the DoxyPEP study / Implementation…
Data on the newly approved medication Lenacapavir
Review of the changes to the IAS-USA guidelines in Dec 2022
Differential Diagnosis and Evaluation of Brain Lesions
Injectable ART for those with detectable viral loads
Diagnosis and Management of Substance-Induced Psychosis
Considerations in primary care for patients using…